L’Oréal Issues Voluntary Recall of Benzoyl Peroxide Products Over Benzene Concerns

March 11, 2025

L’Oréal announced it is recalling all lots of its acne treatment Effaclar Duo in the U.S. due to concerns over benzene contamination. The product, sold under the La Roche-Posay brand, contains benzoyl peroxide (BPO).

Valisure, an independent testing laboratory, first reported benzene contamination in several BPO-containing acne products more than a year ago, urging the US Food and Drug Administration (FDA) to take action.

Read further analysis at Dermatology Times >>

Previous coverage of reports studying benzene presence in topical acne products formulated with benzoyl peroxide:

Topics in Article

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • The Beauty Health Company (SKIN) Rebrands to SkinHealth Systems
    • Amazon Launches GLP-1 Weight Loss Program with One Medical
    • Botox Cosmetic’s “The Confidence Collective” to Empower 250 Women Entrepreneurs
    • Medical Spa Show 2027 Call for Presentations Now Open
    • FDA Warning Letter to Texas Medical Spa Signals Increased Compliance Enforcement